FY26-27 Adult Covid-19 Vaccines

The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, is soliciting proposals for one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts to procure FDA-approved COVID-19 vaccines for adults aged 19 and older. The primary objective is to support the Section 317 immunization program, which distributes vaccines to state and local health departments, including all fifty state health departments, several large city programs, and U.S. Territories serving populations at greatest risk for under-vaccination. Offerors must submit firm-fixed pricing proposals that comply with Federal Excise Tax requirements ($0.75 per dose) and do not exceed the manufacturer's Federal Ceiling Price established by the Department of Veterans Affairs. Vaccines must have a minimum 12-month shelf life upon delivery and be manufactured under current FDA establishment and product licenses in compliance with Current Good Manufacturing Practice Regulations. Non-small business offerors must submit acceptable subcontracting plans with specific targets including 9.37% small business participation, 2.17% small disadvantaged business, 0.70% HUBZone, 1.44% women-owned small business, and 2.33% service-disabled veteran-owned small business. Proposals are due by March 17, 2026, at 1:00 PM EST via email to the specified contracting officers, with the point of contact being Jariya Taylor at 770-488-5452.

This solicitation has no set-aside designation and represents an unrestricted acquisition with a combined maximum contract value of $892,363,500 across all awards. The contract covers vaccine procurement for both the 2026-2027 season (primary focus) and the 2025-2026 season, with a minimum order size of 100 doses per delivery order and a maximum of 10 million doses per vaccine offering. The contract period runs from award through 12 months thereafter, with deliveries required within 15 working days of order placement through the Vaccine Tracking System (VTrckS). Delivery must be made F.O.B. destination to CDC centralized distribution locations in Olive Branch, Mississippi and Clermont, Kentucky, as well as to five CDC Occupational Health Clinic locations as directed. The place of performance is listed as Chamblee, Georgia, though all contract activities are coordinated through the CDC's Office of Acquisition Services in Atlanta, Georgia. Additionally, all manufacturers must execute an Authorized Distributor of Record (ADR) Agreement with the CDC under the Prescription Drug Marketing Act of 1988 to establish the ongoing distribution relationship.